Frontage Genomics successfully completed the Sponsor's request to transfer a method developed on MiSeq to MiniSeq.
Thank you for registering!
You now have the option of downloading the resource or viewing the web version below.
In this podcast, we discuss the importance of understanding the role of Safety Pharmacology in your IND filing with special guest: Chris Elders, Study Director at Frontage Laboratories, Inc.
Frontage Holdings Corporation (“Frontage Holdings” or “Frontage,” stock code: 1521.HK), a Contract Research Organization (“CRO”) providing integrated, science-driven research, analytical and product development services in both the U.S. and China, announced today the opening of a new lab facility in Shanghai, China.
In this eBook, we navigate the landscape of biomarker discovery through genomic profiling, exploring technologies, methods, and applications. We hope this collection of articles creates an appreciation for the wide scope of using sequencing assays for biomarker discovery, drug development, and beyond.